Michał Żuk

6PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)NanomaterialsGene and molecular therapyMicro- and nanosystems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 29, 2023
198Au-Coated Superparamagnetic Iron Oxide Nanoparticles for Dual Magnetic Hyperthermia and Radionuclide Therapy of Hepatocellular Carcinoma.

Nasrin Abbasi Gharibkandi, Michał Żuk, Fazilet Zumrut Biber Muftuler

|Aug 26, 2022
Multifunctional Nanoparticles Based on Iron Oxide and Gold-198 Designed for Magnetic Hyperthermia and Radionuclide Therapy as a Potential Tool for Combined HER2-Positive Cancer Treatment.

Michał Żuk, Rafał Podgórski, Anna Ruszczyńska

|Mar 10, 2022
Synthesis and Characterization of Magnetic Drug Carriers Modified with Tb3+ Ions.

Dorota Nieciecka, Aleksandra Rękorajska, Dariusz Cichy

|Nov 27, 2021
Hybrid Radiobioconjugated Superparamagnetic Iron Oxide-Based Nanoparticles for Multimodal Cancer Therapy.

Michał Żuk, Weronika Gawęda, Agnieszka Majkowska-Pilip

|Feb 29, 2020
Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with 225Ac as a Perspective Tool for Combined α-Radioimmunotherapy and Magnetic Hyperthermia of HER2-Positive Breast Cancer.

Edyta Cędrowska, Marek Pruszyński, Weronika Gawęda

|Feb 13, 2020
Lanthanide-Doped SPIONs Bioconjugation with Trastuzumab for Potential Multimodal Anticancer Activity and Magnetic Hyperthermia.

Weronika Gawęda, Magdalena Osial, Michał Żuk

Pageof 1

Frequent Collaborators

5 joint publications

Aleksander Bilewicz

3 joint publications

Paweł Krysiński

2 joint publications

Agnieszka Majkowska-Pilip

1 joint publications

Marek Pękała